07:05 AM EDT, 07/11/2024 (MT Newswires) -- Novo Nordisk ( NVO ) has partnered with Bio Farma, Indonesia's state-owned pharmaceutical company, to package insulin in Indonesia, Reuters reported on Wednesday, citing a Bio Farma senior official.

The report said the agreement, focused on insulin packaging, does not involve production, which Novo Nordisk ( NVO ) handles in Denmark and the United States.

The investment value or when production will begin is still being finalized, Soleh Ayubi, Bio Farma's deputy chief executive officer, told Reuters, adding that this is the first of Novo Nordisk's ( NVO ) manufacturing deals in Indonesia.

Novo Nordisk ( NVO ) and Bio Farma did not immediately respond to requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 141.87, Change: -0.87, Percent Change: -0.61